Ten years ago, smokers relied mostly on nicotine replacement therapies like patches and gums when they wanted to kick the habit. But that has all changed thanks to electronic cigarettes. As the ecig market continues to grow by leaps and bounds, Big Pharma is feeling the heat with profits falling every month.
It’s reported that e-cigs had really caused the drug company to reconsider its approach to smoking cessation. Many drug-makers had even considered developing their own version of an electronic cigarette to compete in the growing market.
Over the past two years, there has been a plethora of research about how e-cigs impact smoking cessation and it’s clear that vaping works. In fact, a recent study revealed that smokers are more likely to successfully kick the cigarette habit by using Starbuzz e-cigs than if they relied on cold turkey methods or traditional nicotine replacement therapies like nicotine patches. Smokers like using Starbuzz e-cigs as an alternative because they offer nicotine replacement in a familiar form. They can still enjoy the act of smoking by inhaling a nicotine vapor, but the tobacco and tar is eliminated to drastically reduce health risks.
Even with an abundance of evidence to suggest that e-cigs are the best avenue for smokers that want to quit, a few pharma will continue offering nicotine gum, patches, and medications in hopes to attract smokers that are not sold on the ecig concept. We will have to wait to see if they will change their position in the future. Would it be a smart move for Big Pharma to launch their own line of electronic cigarettes? Would this ultimately help or hurt the growing e-cigarette industry? You can share your views at our blog or our online store.
Success Story from Jose Garcia